Alejandro Piris‐Giménez
Vall d'Hebron Hospital Universitari · 24 works · 1,853 citations · h-index 12
Top works
- Caring for patients with cancer in the COVID-19 era
- Interrogating open issues in cancer precision medicine with patient-derived xenografts
- Primary Involvement of Pharynx and Peyer's Patch in Inhalational and Intestinal Anthrax
- The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
- New clinical trial designs in the era of precision medicine
- RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
- Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
- High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin
- In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax
- Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts
- EncapsulatedBacillus anthracisInteracts Closely with Liver Endothelium
- In Vivo Germination of Bacillus anthracis Spores During Murine Cutaneous Infection
- Author Correction: Caring for patients with cancer in the COVID-19 era
- Basket of baskets (BoB): A modular, open label, phase II, multicenter study to evaluate targeted agents in molecularly selected populations with advanced solid tumors.
- ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
- Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
- Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
- Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally
- Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers
- Abstract 985: The EurOPDX EDIReX project: Towards a European research infrastructure on patient-derived cancer models